Clinical trial Recruiting at 2 sites Interventional Ages 60 and up

AI-supported social help for older adults with chronic heart failure

Official title: Gendered Psychosocial Pathways of Social Frailty in Older Adults With Heart Failure: A Longitudinal Study of an AI-Based Conversational Social-Support Intervention.

Run by Chang Gung University of Science and Technology · NCT07862933 · Data updated 2026-11-12

Researchers will test whether an AI chat-based social support program can help older adults with chronic heart failure feel less socially frail and stay active, compared with regular social activities or usual care.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment174 (estimated)
SponsorChang Gung University of Science and Technology
Academic / other
Locations2 sites (New Taipei City, New Taipei City and 1 other locations)
StatusRecruiting
StartedNovember 5, 2025
Main results expectedJuly 2028
Study endsJuly 31, 2028
Registry record updatedOctober 16, 2026
Trial IDNCT07862933 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 or older with chronic heart failure who can communicate in Mandarin or Taiwanese and have access to or can be provided with AI-enabled devices and internet.

Probably not a fit

Participants with unstable heart failure, severe comorbidities, major cognitive or communication impairments, or uncorrected sensory deficits may derive limited or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses a mixed design over three years to explore gender differences in social frailty among older adults with chronic heart failure in Taiwan. Phase 1 assesses baseline clinical features, sarcopenia, physical activity, and multidimensional frailty, using models to identify factors linked to social frailty. Phase 2 randomizes 174 participants into three groups: AI-based conversational social support, community social participation, and control, with assessments before and after the 15–30 minute daily AI interactions or participation activities. Phase 3 follows participants for 12 months to evaluate the durability of any observed effects on emotional state, physical activity, and social frailty. The study combines cross-sectional analysis with an embedded intervention trial and longitudinal follow-up.

Why it matters

Potential benefit: If successful, the AI-based intervention could reduce social frailty and improve well-being and activity levels for older adults with CHF.

How similar studies have gone: Prior work in digital social support has shown promise in related populations, but this specific AI-based conversational approach for CHF-related social frailty is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants aged 60 years or older.
2. Diagnosis of chronic heart failure (CHF).
3. Ability to communicate effectively in Mandarin or Taiwanese.

Exclusion Criteria:

1. Unstable heart failure.
2. Severe comorbidities, such as end-stage renal disease, advanced hepatic dysfunction, or terminal malignancies.
3. Severe cognitive deficits that impede the ability to provide informed consent or participate in study interventions.
4. Uncorrected visual or hearing impairments that hinder effective communication or interaction with the AI-based conversational social-support intervention.
5. Active psychiatric conditions, including major depression or psychosis, that could interfere with study participation or adherence.

Where it's running

  • New Taipei Municipal Tucheng Hospital (Built and Operated by Chang Gung Medical Foundation)
    New Taipei City, New Taipei City, Taiwan
    Recruiting
  • Chang Gung Memorial Hospital, Linkou
    Taoyuan, Taoyuan City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.